Literature DB >> 33780889

An explainable machine learning algorithm for risk factor analysis of in-hospital mortality in sepsis survivors with ICU readmission.

Zhengyu Jiang1, Lulong Bo2, Zhenhua Xu3, Yubing Song3, Jiafeng Wang2, Pingshan Wen2, Xiaojian Wan2, Tao Yang2, Xiaoming Deng2, Jinjun Bian4.   

Abstract

BACKGROUND AND
OBJECTIVE: Patients who survive sepsis in the intensive care unit (ICU) (sepsis survivors) have an increased risk of long-term mortality and ICU readmission. We aim to identify the risk factors for in-hospital mortality in sepsis survivors with later ICU readmission and visualize the quantitative relationship between the individual risk factors and mortality by applying machine learning (ML) algorithm.
METHODS: Data were obtained from the Medical Information Mart for Intensive Care III (MIMIC-III) database for sepsis and non-sepsis ICU survivors who were later readmitted to the ICU. The data on the first day of ICU readmission and the in-hospital mortality was combined for the ML algorithm modeling and the SHapley Additive exPlanations (SHAP) value of the correlation between the risk factors and the outcome.
RESULTS: Among the 2970 enrolled patients, in-hospital mortality during ICU readmission was significantly higher in sepsis survivors (n = 2228) than nonsepsis survivors (n = 742) (50.4% versus 30.7%, P<0.001). The ML algorithm identified 18 features that were associated with a risk of mortality in these groups; among these, BUN, age, weight, and minimum heart rate were shared by both groups, and the remaining mean systolic pressure, urine output, albumin, platelets, lactate, activated partial thromboplastin time (APTT), potassium, pCO2, pO2, respiration rate, Glasgow Coma Scale (GCS) score for eye-opening, anion gap, sex and temperature were specific to previous sepsis survivors. The ML algorithm also calculated the quantitative contribution and noteworthy threshold of each factor to the risk of mortality in sepsis survivors.
CONCLUSION: 14 specific parameters with corresponding thresholds were found to be associated with the in-hospital mortality of sepsis survivors during the ICU readmission. The construction of advanced ML techniques could support the analysis and development of predictive models that can be used to support the decisions and treatment strategies made in a clinical setting in critical care patients.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Critical care; Machine learning algorithm; Predictive modeling; Readmission; Sepsis; Sepsis survivor

Year:  2021        PMID: 33780889     DOI: 10.1016/j.cmpb.2021.106040

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  5 in total

1.  E-CatBoost: An efficient machine learning framework for predicting ICU mortality using the eICU Collaborative Research Database.

Authors:  Nima Safaei; Babak Safaei; Seyedhouman Seyedekrami; Mojtaba Talafidaryani; Arezoo Masoud; Shaodong Wang; Qing Li; Mahdi Moqri
Journal:  PLoS One       Date:  2022-05-05       Impact factor: 3.752

2.  Sequential Data-Based Patient Similarity Framework for Patient Outcome Prediction: Algorithm Development.

Authors:  Ni Wang; Muyu Wang; Yang Zhou; Honglei Liu; Lan Wei; Xiaolu Fei; Hui Chen
Journal:  J Med Internet Res       Date:  2022-01-06       Impact factor: 5.428

3.  Analysis of Prognostic Risk Factors of Sepsis Patients in Intensive Care Unit Based on Data Analysis.

Authors:  Lina Yao; Lei Zhang; Chengjie Zhou
Journal:  J Healthc Eng       Date:  2022-01-07       Impact factor: 2.682

4.  Interpretable Machine Learning for Early Prediction of Prognosis in Sepsis: A Discovery and Validation Study.

Authors:  Chang Hu; Lu Li; Weipeng Huang; Tong Wu; Qiancheng Xu; Juan Liu; Bo Hu
Journal:  Infect Dis Ther       Date:  2022-04-10

5.  Explainable Machine Learning-Based Risk Prediction Model for In-Hospital Mortality after Continuous Renal Replacement Therapy Initiation.

Authors:  Pei-Shan Hung; Pei-Ru Lin; Hsin-Hui Hsu; Yi-Chen Huang; Shin-Hwar Wu; Chew-Teng Kor
Journal:  Diagnostics (Basel)       Date:  2022-06-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.